Activity value 75china Buyer&Supplier,Last transaction date:
2026-02-18
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for hangzhou cowin pharma co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 15 transactions, with a transaction quantity of 45975 and a transaction weight of 0.
4sterile
indiabuyer,they trade on 2020-05-28
227.28%
>
5зао синтез
latviabuyer,they trade on 2019-11-05
196.29%
>
+View All
Products
Total 46
ProductsTransactionsPerDetail
tazobactam acid 1729.31%>
nitro 1322.41%>
alu 1220.69%>
yloxy 1118.97%>
dual use 915.52%>
+View All
Hscode rank
Total 19
HSCode NameTransactionsPerDetail
HS 294190902237.93%>
HS 293399901729.31%>
HS 98020000712.07%>
HS 2933799058.62%>
HS 2920900035.17%>
+View All
Trading Area
Total 3
AreaTransactionsPerDetail
india25183.11%>
russia196.29%>
pakistan144.64%>
Port statistics
Total 5
Port NameTransactionsPerDetail
shanghai82.65%>
singapore30.99%>
bangkok10.33%>
beijing10.33%>
bkk10.33%>
hangzhou cowin pharma co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as tazobactam acid,nitro,alu.
According to the 52wmb.com global trade database, as of 2026-02-18, the company has completed 302 international trades,
with its main trading regions covering india,russia,pakistan etc.
The core products include HS29419090,HS29339990,HS98020000 etc,
often transported via shanghai,port singapore, port bangkok etc,
and its main trading partners are sun pharmaceutical industries lilmited,rajasthan antibiotics ltd.,sun pharmaceutical industries ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on hangzhou cowin pharma co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.